Cannabis Law Report

AUGUST 23, 2021

At the end of the programme, Evotec will provide the Company with a submission-ready regulatory document which will be used for submissions to regulatory agencies, as well as drug-batch approved and ready for First Time in Human clinical trials. Since the year-end, the £2.6

Cannabinoids 98

Cannabinoids Research and Development Clinical Trials Packaging 98

MMJ Recs

JULY 9, 2024

Some clinical trials have shown that cannabinoids, particularly THC and CBD, effectively reduce muscle spasticity and pain in MS patients. More rigorous clinical trials are needed to establish clear guidelines for its use in MS management. Featured image by Thirdman on Pexels.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.

Safety 52

Safety Cannabinoids Events Data 52

The Cannigma

AUGUST 31, 2021

The researchers stated that these knowledge gaps must be addressed and that “clinical trial data about how medical cannabis improves patient quality of life domains is desperately needed as this information can impact clinical decision-making.”.

Education 105

Education Clinical Trials Medicine Policy 105

The Cannigma

JULY 1, 2022

Observational studies involve watching the subject and documenting outcomes like a reporter, whereas in interventional studies the researchers take a specific action and monitor the response. This is because these types of studies control the most variables to ensure that the results that come out of the trial are as reliable as possible.

Research and Development 124

Research and Development Data THC Clinical Trials 124

Cannabis Law Report

MARCH 1, 2022

Focus will be on IND/CTA filings and associated interactions, and may include safety reports, protocols, information amendments, responses to requests for information, IND Annual Reports/DSURs, and new investigator amendments. Knowledge of Canadian, Australian and New Zealand clinical trial regulations and procedures is a plus.

Clinical Trials 52

Clinical Trials Environment Pharmaceutical Programs 52

Cannabis Law Report

JULY 30, 2019

Cannabis-based products will be allowed to bypass usual processes required for medicines in New Zealand and go directly onto the market without any proof of safety or effectiveness. This unprecedented proposal is contained in the government’s consultation document on giving greater access to medicinal cannabis.

Medicine 40

Medicine Clinical Trials Safety Access 40

Cannabis Law Report

OCTOBER 2, 2021

Focus will be on IND/CTA filings and associated interactions, and may include safety reports, protocols, information amendments, responses to requests for information, IND Annual Reports/DSURs, and new investigator amendments. Knowledge of Canadian, Australian and New Zealand clinical trial regulations and procedures is a plus.

Clinical Trials 52

Clinical Trials Environment Pharmaceutical Programs 52

Cannabis Law Report

JULY 28, 2021

Cepharanthine is on its way to establishing itself as a once per day, oral anti-cancer therapeutic with a well-established safety profile which will pave the way for an expedited clinical development pathway and future partnering opportunities with pharmaceutical companies. ” Next Steps. ” Next Steps. dcohen@pharmadrug.co.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

MARCH 29, 2020

This “zero recall” standard, the team said, was attributed to the fact that their cannabis product standards with regard to food safety and health was high and involved documentation of over 100 pages. . These are the responsibility of the manufacturer. Setting Standards for Cannabis Research Studies .

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

LifeCannMD

MAY 27, 2025

A leading researcher in cannabis medicine documented something fascinating called the “biphasic effect.” No brain fog, no couch-lock, no wondering if their coworkers could tell they were using medicine. That small difference in pain relief came with a massive difference in quality of life.

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

MMJ Recs

APRIL 10, 2021

The vaccine was designed to protect people from the coronavirus and went through extensive clinical trials to test its safety. Because there are still a lot of unknowns at this time, your best bet is to take some extra steps before you get vaccinated to ensure your safety. Call your doctor.

Clinical Trials 52

Clinical Trials Safety Patients Tincture 52

Healer

DECEMBER 17, 2021

The safety profile of CBD has been acknowledged by major health agencies, such as the World Health Organization (WHO), showing that it’s well-tolerated by animals and humans and rarely produces any dangerous side effects. Numerous studies have shown that CBD is a safe, non-impairing, and non-habit-forming substance.

CBD 98

CBD THC Conditions Medicine 98

WeedAdvisor

AUGUST 3, 2019

Opponents, on the other hand, cite things like safety concerns and lack of research. This means approving the medical cannabis products before clinical trials are complete – a move that does not bode well with some government officials and health organizations. Brazil’s case is no different. Domestic Cultivation and Products.

Clinical Trials 51

Clinical Trials Cultivation Legislation Cannabis 51

TheAnswerPage

JANUARY 11, 2022

For example, most, if not all, states have legalized the use of medical marijuana to treat specific health conditions for which there is no or only poor quality clinical evidence of efficacy and safety. to take a medical marijuana course that reviews the endocannabinoid system and the therapeutic use of marijuana.

Patients 98

Patients Education Marijuana Therapy 98

MMJ Recs

MAY 9, 2024

Veterans can use this journal to document their experiences, including dosage, frequency of use, and any observed changes in symptoms. Clinical Trials and Research: Despite federal restrictions on medical marijuana research, the VA is actively involved in exploring alternative treatments for veterans, including cannabis.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Cannabis Law Report

JANUARY 11, 2019

However, we firmly disagree that the referenced clinical trials are in fact “substantial,” as the trials were extremely limited in scope, and funding and the publication of these trials were limited. CBD has been found to be generally well tolerated with a good safety profile.”.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

Cannabis Law Report

DECEMBER 28, 2021

Upon completion of all the required IND enabling studies and subsequent review by the FDA, Virpax intends to conduct a Phase 1 study to evaluate the relative bioavailability and pharmacokinetics of Epoladerm™ Virpax recently announced the execution of a clinical trial agreement with Altasciences Company, Inc.,

Pharmaceutical 40

Pharmaceutical Research and Development Clinical Trials Chronic Pain 40

MMJ Recs

AUGUST 1, 2024

Safety and Side Effects of Medical Marijuana While medical marijuana delivers many benefits, it still has potential side effects. Patients must familiarize themselves with their jurisdiction’s legal requirements and obtain any necessary documentation, such as a medical marijuana card, to use cannabis legally and responsibly.

Patients 52

Patients Chronic Pain Marijuana Sleep 52

Healer

DECEMBER 17, 2021

The safety profile of CBD has been acknowledged by major health agencies, such as the World Health Organization (WHO), showing that it’s well-tolerated by animals and humans and rarely produces any dangerous side effects. Numerous studies have shown that CBD is a safe, non-impairing, and non-habit-forming substance.

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Framings that more often carried a negative tone were related to poor evidence and safety issues. Bonini et al.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JULY 15, 2022

“Not just the perimeter security, but also the safety and security onsite is paramount.” So without going on to the advertising side of things, very important to have your clinical trials obviously based on products. Most important to have your clinical trials based on the genetics of your plants.

Medicine 52

Medicine Patients Media Supply Chain 52

Cannabis Law Report

JUNE 11, 2019

Given the controversy over the efficacy and safety of cannabis for therapeutic purposes, a key question in these cases, is whether cannabis meets the requirement of medical justification. In rejecting the claim, the court cited Torchia v. Siegrist with approval. ” 42.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement. Wakshlag, DVM, Ph.D.,

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

JULY 21, 2022

Patient safety concerns uncovered during an ongoing federal review have led to the suspension of one of two clinical trials for MDMA-assisted psychotherapy currently underway in Canada. A spokesperson told CBC in an email that the study was put on hold “due to concerns for participant safety.” CBC Canada.

Safety 52

Safety Patients Clinical Trials Data 52

The Cannigma

FEBRUARY 1, 2023

To date, very few human clinical trials have been conducted to assess the effectiveness of THC or CBD in treating cancer. While RSO has been subject to increased popularity in treating certain types of cancers, no clinical trials have tested the safety or efficacy of RSO in humans, meaning that all evidence is anecdotal.

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

CannaMD

MARCH 8, 2021

Authorizing the department to sample marijuana delivery devices from a dispensing facility to determine safety [p. Which begs the question: Why is it okay for Big Pharma to profit from high-potency THC drugs, while Florida patients can’t use high-potency THC medical marijuana to treat documented health conditions under a physician’s care?

THC 116

THC Research and Development Treatment Patients 116

The Cannigma

DECEMBER 12, 2022

He documented his “trip” while riding his bicycle home; now psychedelic enthusiasts celebrate Bicycle Day each year on April 19th. Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. Iboga safety: Numerous concerns about the safety of iboga have been raised by scientists.

History 141

History Microdosing Research and Development Clinical Trials 141

Weedistry

FEBRUARY 4, 2019

And the safety and efficacy of those drugs aren’t even buttressed by a mountain of anecdotal evidence — unlike cannabis use, which has thousands of years of documentation. Just because we don’t yet have clinical trial results that confirm medical cannabis relieves pain, or eases insomnia, or reduces inflammation, etc.,

Clinical Trials 40

Clinical Trials Pharmaceutical Chronic Pain Safety 40

The Cannigma

MARCH 12, 2021

We’re not going to get over the fact that there’s not the same sort of clinical trial and that type of evidence for cannabis and cannabis treatments in the very near future for various reasons. And in my belief, it should be cannabis, because of the safety profile, number one.

Legalization 132

Legalization Patients Education Dispensary 132

The Joint Blog

JANUARY 12, 2020

Passage of the 2018 Farm Bill, which eased federal legal restrictions on hemp cultivation and transport, unleashed a stampede of companies rushing products to the market in an absence of regulations ensuring safety, quality and effectiveness. Still, scientific documentation of CBD’s safety and efficacy is nearly nonexistent.

Pets 36

Pets CBD Clinical Trials Research and Development 36

Cannabis Law Report

JULY 24, 2019

321(v), because they are not generally recognized, among experts qualified by scientific training and experience to evaluate the safety and effectiveness of animal drugs, as safe and effective for use under the conditions prescribed, recommended, or suggested in the labeling. 360b, 360ccc, and 360ccc-l.

CBD 51

CBD Tincture Pets Chronic Pain 51

Cannabis Law Report

JULY 14, 2021

ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States , and a lack of safety for the use of the drug under medical supervision. federal law.

Research and Development 81

Research and Development Clinical Trials Events Treatment 81

Cannabis Law Report

OCTOBER 26, 2019

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. Julie Holland is an American psychopharmacologist, psychiatrist, and author. Ingmar Gorman.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

NORML

JANUARY 28, 2019

The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine. National Library of Medicine has more than 26,000 published studies/reviews across 24 databases regarding cannabis available to read online.

Data 191

Data Clinical Trials Chronic Pain Medicine 191